What are the differential diagnoses for a patient with severe pruritus, scaly hyperkeratotic lesions on the extremities, violaceous papules on the arms and hands, and a skin biopsy showing hyperkeratosis, spongiosis, focal parakeratosis, ichthyosis, and dermal dysplasia?

Differential Diagnosis: Lichen Planus with Overlapping Features

Based on the clinical presentation of violaceous papular lesions on the arms and hands combined with severe pruritus, scaly hyperkeratotic lesions on the extremities, and histopathology showing hyperkeratosis, spongiosis, focal parakeratosis, and ichthyosis, the primary diagnosis is hypertrophic (verrucous) lichen planus, with important differentials including psoriasis, chronic eczema with lichenification, and cutaneous T-cell lymphoma (mycosis fungoides). 1

Clinical Reasoning Algorithm

Primary Diagnosis: Hypertrophic Lichen Planus

The violaceous papules are pathognomonic for lichen planus, particularly when combined with severe pruritus 1. The NCCN 2024 guidelines specifically describe ICI-related lichen planus as "violaceous (dark red/purple) papules and plaques without scale over the trunk and extremities, and significant pruritus" 1. While your patient isn't on immunotherapy, this clinical description matches classic hypertrophic LP.

Key distinguishing features favoring hypertrophic LP:

• Violaceous color of papules (highly specific) 1
• Severe pruritus as dominant symptom 1
• Hyperkeratotic lesions on extremities (typical distribution for hypertrophic variant) 2, 3
• Histologic hyperkeratosis with the described features 3

Critical Differential: Psoriasis

Psoriasis remains in the differential because hyperkeratotic plaques on extremities can mimic hypertrophic LP 3. However, several features argue against psoriasis:

• Violaceous color (psoriasis is typically erythematous with silvery scale) 4
• The combination of spongiosis on histology is atypical for psoriasis 4
• Psoriatic plaques typically show more uniform silvery scale rather than the verrucous quality described 4

Important Consideration: Mycosis Fungoides

This is the most critical diagnosis to exclude given the histologic finding of spongiosis combined with hyperkeratosis. Recent evidence shows that mycosis fungoides can present with prominent spongiosis, creating diagnostic confusion 5, 6. A 2019 study specifically highlighted that MF with spongiosis mimics benign inflammatory dermatoses and is often initially misdiagnosed as dermatitis or psoriasis 6.

Red flags requiring exclusion of MF:

• Persistent lesions unresponsive to standard therapy 6
• Spongiosis on histology (unusual but documented in MF) 5, 6
• Hyperpigmented or persistent patches 5

Chronic Eczema with Lichenification

Less likely given the violaceous papules, which are not characteristic of eczematous conditions 7, 8. Chronic eczema typically shows erythema, xerosis, and lichenification without the violaceous hue 8.

Diagnostic Workup Required

Immediate next steps:

1. Immunohistochemistry on existing biopsy specimen - This is non-negotiable to exclude mycosis fungoides:

   • CD3, CD4, CD8, CD20 markers 5
   • Look for atypical lymphocytes and epidermotropism 6
   • T-cell receptor gene rearrangement if immunohistochemistry is equivocal 4

2. Dermatoscopy of violaceous papules - Look for:

   • Wickham's striae (white lines) supporting LP 1
   • Absence of typical psoriatic features 9

3. Examine oral mucosa and nails carefully - Oral involvement or nail changes support LP diagnosis 1, 2

4. Consider repeat biopsy if initial specimen inadequate - Multiple biopsies may be needed for definitive diagnosis, particularly to rule out cutaneous lymphoma 4, 6

Common Diagnostic Pitfalls

Critical warning: Hypertrophic LP is frequently misdiagnosed as psoriasis and treated unsuccessfully with biologics 3. One case report described a patient treated extensively for "psoriasis" until biopsy revealed hypertrophic LP 3. Do not initiate biologic therapy without histologic confirmation.

Spongiosis creates confusion: The presence of spongiosis on your biopsy is unusual but documented in both LP variants and MF 5, 6. This finding should not exclude either diagnosis but mandates immunohistochemistry to differentiate inflammatory from neoplastic processes 6.

The "dermal dysplasia" mentioned requires clarification - This term is non-specific. If this refers to atypical keratinocytes or lymphocytes, MF becomes more likely and requires immediate hematopathology consultation 4.

Treatment Implications Based on Diagnosis

If hypertrophic LP confirmed:

• High-potency topical corticosteroids (clobetasol 0.05%) 1, 2, 3
• Systemic options: acitretin, hydroxychloroquine 3
• Narrow-band UVB phototherapy 1

Do not use biologic therapy designed for psoriasis if this is hypertrophic LP - these typically fail in LP and delay appropriate treatment 3.